Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.

J Wang, K Helin, P Jin, B Nadal-Ginard

    61 Citations (Scopus)

    Abstract

    Terminal differentiation of cultured myocytes requires withdrawal of the cells from the cell cycle. Constitutive overexpression of several oncogenes in myoblasts can inhibit in vitro myogenesis. Here we studied the role of the cellular transcription factor E2F1 on myogenic differentiation. E2F1 expression is irreversibly down-regulated during differentiation of C2C12 myocytes. Furthermore, deregulated E2F1 expression in C2C12 cells prevented myogenic differentiation. This inhibition of myogenesis was associated with the repression of myogenin expression and an elevated cyclin D1 expression. Moreover, E2F1-overexpressing myocytes failed to exit the cell cycle under differentiation conditions. These results are consistent with the notion that E2F1 can function as an oncogene and further suggest that E2F1 down-regulation is required for myogenic differentiation.
    Original languageEnglish
    JournalMolecular Cancer Research
    Volume6
    Issue number10
    Pages (from-to)1299-306
    Number of pages7
    ISSN1541-7786
    Publication statusPublished - 1995

    Fingerprint

    Dive into the research topics of 'Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.'. Together they form a unique fingerprint.

    Cite this